This mutant produces ribostamycin, but almost no neamine is produced.
突变株产生核糖霉素的同时基本未产生新霉胺。
By mutagenic treatment of spores of the Streptomyces ribosidificus 3719 A51-1, mutant 3-18 was obtained. This mutant produces ribostamycin, but almost no neamine is produced.
将核糖苷链霉菌3719-A51-1的孢子经诱变处理后，得到一突变株3-18，它在产生核糖霉素的同时在发酵后期，基本上未发现新霉胺。
By mutagenic treatment of spores of the Streptomyces ribosidificus 3719 A51-1, mutant 3-18 was obtained. This mutant produces ribostamycin, but almost no neamine is produced.
将核糖苷链霉菌3719-A51-1的孢子经诱变处理后，得到一突变株3-18，它在产生核糖霉素的同时在发酵后期，基本上未发现新霉胺。
应用推荐